JAZZ – jazz pharmaceuticals plc - ordinary shares (US:NASDAQ)
Stock Stats
News
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $200.00 price target on the stock.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Barclays PLC from $230.00 to $200.00. They now have an "overweight" rating on the stock.
Jazz Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $222.00 price target on the stock.
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
Form 10-Q Jazz Pharmaceuticals For: Mar 31
Form 8-K Jazz Pharmaceuticals For: May 01
Form 10-K/A Jazz Pharmaceuticals For: Dec 31
Form 4 Jazz Pharmaceuticals For: Apr 05 Filed by: GALA RENEE D
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.